171 related articles for article (PubMed ID: 12783859)
1. ATP binding to the first nucleotide binding domain of multidrug resistance-associated protein plays a regulatory role at low nucleotide concentration, whereas ATP hydrolysis at the second plays a dominant role in ATP-dependent leukotriene C4 transport.
Yang R; Cui L; Hou YX; Riordan JR; Chang XB
J Biol Chem; 2003 Aug; 278(33):30764-71. PubMed ID: 12783859
[TBL] [Abstract][Full Text] [Related]
2. ATP binding to the first nucleotide-binding domain of multidrug resistance protein MRP1 increases binding and hydrolysis of ATP and trapping of ADP at the second domain.
Hou YX; Cui L; Riordan JR; Chang XB
J Biol Chem; 2002 Feb; 277(7):5110-9. PubMed ID: 11741902
[TBL] [Abstract][Full Text] [Related]
3. Nucleotide dissociation from NBD1 promotes solute transport by MRP1.
Yang R; McBride A; Hou YX; Goldberg A; Chang XB
Biochim Biophys Acta; 2005 Mar; 1668(2):248-61. PubMed ID: 15737336
[TBL] [Abstract][Full Text] [Related]
4. Role of carboxylate residues adjacent to the conserved core Walker B motifs in the catalytic cycle of multidrug resistance protein 1 (ABCC1).
Payen LF; Gao M; Westlake CJ; Cole SP; Deeley RG
J Biol Chem; 2003 Oct; 278(40):38537-47. PubMed ID: 12882957
[TBL] [Abstract][Full Text] [Related]
5. Interaction between the bound Mg.ATP and the Walker A serine residue in NBD2 of multidrug resistance-associated protein MRP1 plays a crucial role for the ATP-dependent leukotriene C4 transport.
Yang R; Scavetta R; Chang XB
Biochemistry; 2008 Aug; 47(32):8456-64. PubMed ID: 18636743
[TBL] [Abstract][Full Text] [Related]
6. Function of the ABC signature sequences in the human multidrug resistance protein 1.
Ren XQ; Furukawa T; Haraguchi M; Sumizawa T; Aoki S; Kobayashi M; Akiyama S
Mol Pharmacol; 2004 Jun; 65(6):1536-42. PubMed ID: 15155846
[TBL] [Abstract][Full Text] [Related]
7. ATP binding, not hydrolysis, at the first nucleotide-binding domain of multidrug resistance-associated protein MRP1 enhances ADP.Vi trapping at the second domain.
Hou YX; Riordan JR; Chang XB
J Biol Chem; 2003 Feb; 278(6):3599-605. PubMed ID: 12458196
[TBL] [Abstract][Full Text] [Related]
8. Replacement of the positively charged Walker A lysine residue with a hydrophobic leucine residue and conformational alterations caused by this mutation in MRP1 impair ATP binding and hydrolysis.
Buyse F; Hou YX; Vigano C; Zhao Q; Ruysschaert JM; Chang XB
Biochem J; 2006 Jul; 397(1):121-30. PubMed ID: 16551273
[TBL] [Abstract][Full Text] [Related]
9. Mutation of the aromatic amino acid interacting with adenine moiety of ATP to a polar residue alters the properties of multidrug resistance protein 1.
Zhao Q; Chang XB
J Biol Chem; 2004 Nov; 279(47):48505-12. PubMed ID: 15355964
[TBL] [Abstract][Full Text] [Related]
10. Hydrogen-bond formation of the residue in H-loop of the nucleotide binding domain 2 with the ATP in this site and/or other residues of multidrug resistance protein MRP1 plays a crucial role during ATP-dependent solute transport.
Yang R; Chang XB
Biochim Biophys Acta; 2007 Feb; 1768(2):324-35. PubMed ID: 17187755
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the functional characteristics of the nucleotide binding domains of multidrug resistance protein 1.
Gao M; Cui HR; Loe DW; Grant CE; Almquist KC; Cole SP; Deeley RG
J Biol Chem; 2000 Apr; 275(17):13098-108. PubMed ID: 10777615
[TBL] [Abstract][Full Text] [Related]
12. Functional interactions between nucleotide binding domains and leukotriene C4 binding sites of multidrug resistance protein 1 (ABCC1).
Payen L; Gao M; Westlake C; Theis A; Cole SP; Deeley RG
Mol Pharmacol; 2005 Jun; 67(6):1944-53. PubMed ID: 15755910
[TBL] [Abstract][Full Text] [Related]
13. The Walker B motif of the second nucleotide-binding domain (NBD2) of CFTR plays a key role in ATPase activity by the NBD1-NBD2 heterodimer.
Stratford FL; Ramjeesingh M; Cheung JC; Huan LJ; Bear CE
Biochem J; 2007 Jan; 401(2):581-6. PubMed ID: 16989640
[TBL] [Abstract][Full Text] [Related]
14. Analysis of the AAA sensor-2 motif in the C-terminal ATPase domain of Hsp104 with a site-specific fluorescent probe of nucleotide binding.
Hattendorf DA; Lindquist SL
Proc Natl Acad Sci U S A; 2002 Mar; 99(5):2732-7. PubMed ID: 11867765
[TBL] [Abstract][Full Text] [Related]
15. Drug binding in human P-glycoprotein causes conformational changes in both nucleotide-binding domains.
Loo TW; Bartlett MC; Clarke DM
J Biol Chem; 2003 Jan; 278(3):1575-8. PubMed ID: 12421806
[TBL] [Abstract][Full Text] [Related]
16. The First Nucleotide Binding Domain of Cystic Fibrosis Transmembrane Conductance Regulator Is a Site of Stable Nucleotide Interaction, whereas the Second Is a Site of Rapid Turnover.
Aleksandrov L; Aleksandrov AA; Chang XB; Riordan JR
J Biol Chem; 2002 May; 277(18):15419-25. PubMed ID: 11861646
[TBL] [Abstract][Full Text] [Related]
17. Covalent modification of the nucleotide binding domains of cystic fibrosis transmembrane conductance regulator.
Cotten JF; Welsh MJ
J Biol Chem; 1998 Nov; 273(48):31873-9. PubMed ID: 9822656
[TBL] [Abstract][Full Text] [Related]
18. Residues responsible for the asymmetric function of the nucleotide binding domains of multidrug resistance protein 1.
Qin L; Zheng J; Grant CE; Jia Z; Cole SP; Deeley RG
Biochemistry; 2008 Dec; 47(52):13952-65. PubMed ID: 19063607
[TBL] [Abstract][Full Text] [Related]
19. Allosteric interactions between the two non-equivalent nucleotide binding domains of multidrug resistance protein MRP1.
Hou Y; Cui L; Riordan JR; Chang X
J Biol Chem; 2000 Jul; 275(27):20280-7. PubMed ID: 10781583
[TBL] [Abstract][Full Text] [Related]
20. Mutations of the Walker B motif in the first nucleotide binding domain of multidrug resistance protein MRP1 prevent conformational maturation.
Cui L; Hou YX; Riordan JR; Chang XB
Arch Biochem Biophys; 2001 Aug; 392(1):153-61. PubMed ID: 11469806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
